Literature DB >> 8376841

Kinetic and antigenic characterization of altered protein synthesis by Campylobacter jejuni during cultivation with human epithelial cells.

M E Konkel1, D J Mead, W Cieplak.   

Abstract

Cultivation of Campylobacter jejuni with INT 407 cell monolayer cultures results in new or enhanced synthesis of a number of proteins compared with bacteria cultured in the absence of the epithelial cells. These proteins were detected within 60 min after the addition of the bacteria to the epithelial cell cultures, and their synthesis was temporally associated with an increase in C. jejuni internalization. A rabbit antiserum raised against bacteria that were cultivated with INT 407 cells recognized nine proteins that were not recognized by an antiserum against C. jejuni cultivated in medium alone. The former antiserum inhibited the internalization, but not the binding, of Campylobacter jejuni in a dose-dependent fashion. The results suggest that one or more of the proteins synthesized by C. jejuni in response to cocultivation with epithelial cells plays a role in facilitating internalization.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8376841     DOI: 10.1093/infdis/168.4.948

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Development of a recombinant epsilon toxoid vaccine against enterotoxemia and its use as a combination vaccine with live attenuated sheep pox virus against enterotoxemia and sheep pox.

Authors:  Dev Chandran; Sureddi Satyam Naidu; Parthasarathy Sugumar; Gudavalli Sudha Rani; Shahana Pallichera Vijayan; Deepika Mathur; Lalit C Garg; Villuppanoor Alwar Srinivasan
Journal:  Clin Vaccine Immunol       Date:  2010-04-28

2.  Fibronectin-facilitated invasion of T84 eukaryotic cells by Campylobacter jejuni occurs preferentially at the basolateral cell surface.

Authors:  Marshall R Monteville; Michael E Konkel
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

3.  Identification of Campylobacter jejuni genes involved in its interaction with epithelial cells.

Authors:  Veronica Novik; Dirk Hofreuter; Jorge E Galán
Journal:  Infect Immun       Date:  2010-06-01       Impact factor: 3.441

4.  The focal complex of epithelial cells provides a signalling platform for interleukin-8 induction in response to bacterial pathogens.

Authors:  Tyson P Eucker; Derrick R Samuelson; Mary Hunzicker-Dunn; Michael E Konkel
Journal:  Cell Microbiol       Date:  2014-06-02       Impact factor: 3.715

5.  Campylobacter jejuni FlpA binds fibronectin and is required for maximal host cell adherence.

Authors:  Michael E Konkel; Charles L Larson; Rebecca C Flanagan
Journal:  J Bacteriol       Date:  2010-01       Impact factor: 3.490

6.  Culture of Campylobacter jejuni with sodium deoxycholate induces virulence gene expression.

Authors:  Preeti Malik-Kale; Craig T Parker; Michael E Konkel
Journal:  J Bacteriol       Date:  2008-01-25       Impact factor: 3.490

7.  Cloning, sequencing, and expression of a gene from Campylobacter jejuni encoding a protein (Omp18) with similarity to peptidoglycan-associated lipoproteins.

Authors:  M E Konkel; D J Mead; W Cieplak
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

8.  Identification of a Campylobacter jejuni-secreted protein required for maximal invasion of host cells.

Authors:  Jeffrey E Christensen; Sophia A Pacheco; Michael E Konkel
Journal:  Mol Microbiol       Date:  2009-07-14       Impact factor: 3.501

9.  The Campylobacter jejuni CiaD effector protein activates MAP kinase signaling pathways and is required for the development of disease.

Authors:  Derrick R Samuelson; Tyson P Eucker; Julia A Bell; Leslie Dybas; Linda S Mansfield; Michael E Konkel
Journal:  Cell Commun Signal       Date:  2013-10-21       Impact factor: 5.712

10.  Serine phosphorylation of cortactin is required for maximal host cell invasion by Campylobacter jejuni.

Authors:  Derrick R Samuelson; Michael E Konkel
Journal:  Cell Commun Signal       Date:  2013-11-04       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.